Navigation Links
Infertile Voice Supports Stem Cell Research: RESOLVE Calls for,Patient Options in Using Frozen Embryos

New survey shows more than half of infertile couples willing to donate unused embryos for stem cell research

BETHESDA, Md., June 20, 2007 /PRNewswire/ -- RESOLVE: The National Infertility Association issued the following statement today, in anticipation of President Bush's veto of federal legislation that would loosen current limitations on stem cell research:

"President Bush is choosing to ignore the potential life-saving gift the infertility community is willing to give to support stem cell research - the gift of unused embryos to advance science and to help develop treatments for diseases such as cancer, diabetes and other debilitating illnesses," said Barbara Collura, Executive Director of RESOLVE: The National Infertility Association.

A recent survey of over two thousand infertile women and men with unused frozen embryos as a result of infertility treatment revealed that 60 percent would likely donate their unused embryos for stem cell research. According to Duke University Medical Center and Johns Hopkins University researchers who conducted the survey, these findings suggest that there may be upwards of 100,000 frozen embryos that could be made available for research.

"When faced with the highly emotional decision to either destroy unused embryos, donate them to another infertile couple or donate them to research, for the majority of infertile women and men, the option to donate their embryos to advance research and benefit society is the preferred choice," Collura added. "We applaud Duke and Johns Hopkins for bringing forth the patient voice in this debate. The message is loud and clear. Donating unused embryos for stem cell research is an option that should be given to infertile women and men."

"RESOLVE further believes that infertility patients should be free from interference in making the very personal decision about the uses of their own body tissues, including reproduct ive tissues and fertilized reproductive tissues," said Collura.

Founded in 1974, RESOLVE: The National Infertility Association, headquartered in Bethesda, MD, is the oldest and largest consumer-based, nonprofit group that provides education, advocacy and compassionate support for those struggling with infertility in the United States. Each year, RESOLVE and its nationwide network of affiliates and chapters handle more than 1.5 million contacts from people seeking information and help. For more information, visit the RESOLVE website at http://www.resolve.org.

    CONTACT:  Gina Cella

              Cella Communications

              Tel: 781-334-4692

              

ginacella@comcast.net

CONTACT: Gina Cella of Cella Communications for RESOLVE, +1-781-334-4692, ginacella@comcast.net

Web site: http://www.resolve.org//

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Related medicine technology :

1. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
2. Data Showing that ReGens Colostrinin Supports Healthy Cognitive Function Presented at the 2007 International Congress on Natural Medicine in Australia
3. Study Supports Cost-Effectiveness of Medtronics Spasticity Treatment for Children with Cerebral Palsy
4. From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
5. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
6. Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse
7. BioCryst Presents Phase I Peramivir Data at the Options for the Control of Influenza Conference
8. Data on Telavancin and Micafungin Hold Promise of New Therapeutic Options in Fight Against Serious Infectious Disease
9. Study Sheds Light on Medication Treatment Options for Bipolar Disorder
10. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
11. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... Dublin ... of the " Global Markets for Spectroscopy Equipment" ... This report focuses on the global ... including its applications in various applications. The report deals ... three main industries: pharmaceutical and biotechnology, food and beverage, ...
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
Breaking Medicine Technology:
(Date:6/27/2016)... California (PRWEB) , ... June 27, 2016 , ... "FCPX ... fully customizable inside of Final Cut Pro X," said Christina Austin - CEO of ... unique style. Final Cut Pro X users can now reveal the media ...
(Date:6/27/2016)... Park, KS (PRWEB) , ... June 27, 2016 , ... ... in retailers of Eyeglasses . , Millions of individuals in the United States ... eyeglasses have become a way to both correct vision and make a fashion statement. ...
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
Breaking Medicine News(10 mins):